Synapse - Efsevia Vakiani

Results (265)

Calretinin positivity in poorly differentiated colorectal carcinoma: A diagnostic pitfall

Meeting Abstract

Liu, S.; Rao, D.; Hechtman, J.; Vakiani, E.; Klimstra, D. S.; Shia, J.
Laboratory Investigation (2017)

HER2/ERBB2 amplification in colorectal carcinoma is associated with KRAS wild type status, microsatellite stability, and left sided tumors

Meeting Abstract

Cotzia, P.; Alex, D.; Middha, S.; Hechtman, J.; Liu, S.; Rao, D.; Vakiani, E.; Klimstra, D. S.; Shia, J.
Laboratory Investigation (2017)

Fulltext@MSK | Save

Expression of PD-L1 in colorectal carcinoma (CRC) primarily occurs in stromal/immune cells at tumor-stroma interface (TSI), and is associated with high tumor-infiltrating lymphocytes (TILs) irrespective of the microsatellite instability (MSI) status or the molecular mechanism of MSI

Meeting Abstract

Liu, S.; Hechtman, J.; Segal, N.; Smith, J.; Rao, D.; Markowitz, A.; Weiser, M.; Vakiani, E.; Klimstra, D. S.; Stadler, Z.; more...
Laboratory Investigation (2017)

Fulltext@MSK | Save

Clinical and genetic determinants of ovarian metastases from colorectal cancer

Journal Article

Ganesh, K.; Shah, R. H.; Vakiani, E.; Nash, G. M.; Skottowe, H. P.; Yaeger, R.; Cercek, A.; Lincoln, A.; Tran, C.; Segal, N. H.; more...
Cancer (2017)

Fulltext@MSK | Save

Diagnosing colorectal medullary carcinoma: Interobserver variability and clinicopathological implications

Journal Article

Lee, L. H.; Yantiss, R. K.; Sadot, E.; Ren, B.; Calvacanti, M. S.; Hechtman, J. F.; Ivelja, S.; Huynh, B.; Xue, Y.; Shitilbans, T.; more...
Human Pathology (2017)

Fulltext@MSK | Save

Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases

Journal Article

Frankel, T. L.; Vakiani, E.; Nathan, H.; DeMatteo, R. P.; Kingham, T. P.; Allen, P. J.; Jarnagin, W. R.; Kemeny, N. E.; Solit, D. B.; D'Angelica, M. I.
Cancer (2017)

Fulltext@MSK | Save

Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Schwann cells activated by cancer cells induce cancer cell invasion

Meeting Abstract

Deborde, S.; Omelchenko, T. A.; Lyubchik, A.; Zhou, Y.; He, S.; McNamara, W.; Chernichenko, N.; Lee, S.; Chen, C.; Bakst, R.; more...
Molecular Biology of the Cell (2016)

Fulltext@MSK | Save

Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade

Meeting Abstract

Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma

Journal Article

Lee, L. H.; Cavalcanti, M. S.; Segal, N. H.; Hechtman, J. F.; Weiser, M. R.; Smith, J. J.; Garcia-Aguilar, J.; Sadot, E.; Ntiamoah, P.; Markowitz, A. J.; more...
Modern Pathology (2016)

Fulltext@MSK | Save